InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

新天药业 (002873.SZ) — directors' dealings · MAR Art. 19 · 9 disclosures

← Companies ★ Sign in to follow

新天药业: directors' dealings · France · AMF

SZSE:002873FRFR·AMFMcap 2.4Bn€

Explore the full directors' dealings record of 新天药业, a publicly traded company based in France. Shares trade on FR FR, under the oversight of AMF. Market capitalisation: €2.4bn. The latest transaction was filed on 18 December 2025 — Sale. Among the most active insiders: 陈珏蓉. All data is free.

9

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

9 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

9.78 €

Income statement

Revenue749.7 M€

Gross profit536.6 M€72% margin

Net income9.1 M€1.2% margin

Balance sheet & cash

Market cap2.42 Bn€

Total debt668.9 M€

Free Cash Flow32.1 M€

Last declaration on 18 December 2025

All Executives9 Thresholds Prospectus Other

Declarations9 total

Executives●Sale22SZSE

上

上海新天智药生物技术有限公司董事长,总经理

2,190,500 shares

A股XSHE

SZSE:273000000052638400·18 Dec 2025

Executives●Sale11SZSE

陈

陈珏蓉高管

12,000 shares

A股XSHE

SZSE:173000006007403000·2 Nov 2022

Executives●Sale11SZSE

陈

陈珏蓉高管

46,000 shares

A股XSHE

SZSE:173000005962890800·19 Oct 2022

Executives●Sale11SZSE

魏

魏茂陈高管

8,000 shares

A股XSHE

SZSE:173000005962873540·19 Oct 2022

Executives●Sale7SZSE

王

王金华董事,高管

252,000 shares

A股XSHE

SZSE:173000005962873400·19 Oct 2022

Executives●Sale7SZSE

游

游何宇监事

3,400 shares

A股XSHE

SZSE:173000005962873100·19 Oct 2022

Executives●Sale7SZSE

安

安万学监事

19,400 shares

A股XSHE

SZSE:173000005962873570·19 Oct 2022

Executives●Sale11SZSE

周

周伟高管

16,000 shares

A股XSHE

SZSE:173000005962873470·19 Oct 2022

Executives●Sale7SZSE

何

何忠磊董事

3,500 shares

A股XSHE

SZSE:173000005962873200·19 Oct 2022

9 of 9 declarations